Get the Stockscreener App
3.67
0.00%
0.00
After Hours:
3.67
Quanterix Corp stock is traded at $3.67, with a volume of 336.65K.
It is up +0.00% in the last 24 hours and down -15.05% over the past month.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
See More
Previous Close:
$3.67
Open:
$3.71
24h Volume:
336.65K
Relative Volume:
0.30
Market Cap:
$172.88M
Revenue:
$144.98M
Net Income/Loss:
$-104.19M
P/E Ratio:
-1.5505
EPS:
-2.367
Net Cash Flow:
$-82.90M
1W Performance:
-5.90%
1M Performance:
-15.05%
6M Performance:
-44.89%
1Y Performance:
-37.26%
1-Day Range:
$3.65
$3.86
1-Week Range:
$3.65
$4.09
52-Week Range:
$2.395
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Name
Quanterix Corp
Sector
Industry
Phone
617-301-9400
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
3.67 | 172.88M | 144.98M | -104.19M | -82.90M | -2.367 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-01-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-25-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-08-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| May-23-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-15-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-09-22 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-09-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-02-22 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-04-21 | Initiated | Goldman | Sell |
View All
Quanterix Corp Stock (QTRX) Latest News
Quanterix Corp (QTRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Quanterix Corp (QTRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Quanterix Corp (QTRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Quanterix Corp (QTRX) Income Statement - TradingKey
Quanterix Corp (QTRX) Cash Flow - TradingKey
Quanterix Corp (QTRX) Balance Sheet - TradingKey
Quanterix Corp (QTRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QTRX|Quanterix Corp|Price:3.670|Chg%:-0.250 - TradingKey
Quanterix Corp (QTRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomarker Collaboration and Licensing Deals Report 2016-2026Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More - Yahoo Finance
Quanterix stock trades lower despite stronger revenue and margin progress - Ad-hoc-news.de
Form 4 Quanterix Corp For: 16 July By Investing.com - Investing.com Nigeria
Quanterix Corp (QTRX) CTO converts 1,558 RSUs, withholds shares for taxes - Stock Titan
Quanterix Corp (NASDAQ: QTRX) grants 141,820 RSUs to its CFO - Stock Titan
Quanterix CFO’s 141,820-Share Award Vests Over Four Years - Stock Titan
Quanterix (QTRX) Marks Key Milestones in Alzheimer's Testing Adv - GuruFocus
Anthem Blue Cross covers Quanterix Alzheimer’s blood test - Investing.com
Quanterix test found preclinical Alzheimer’s evidence in 20% of cognitively normal adults - Stock Titan
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages - Yahoo Finance
Jason F. Faessler Net Worth (2026) - GuruFocus
Quanterix (QTRX) Stock Fair Value Falls After Analysts Cut Price Targets - Yahoo Finance
Form 4 Quanterix Corp For: 9 July By Investing.com - Investing.com Nigeria
Director Scott Mendel converts 8,073 RSUs at Quanterix (NASDAQ: QTRX) - Stock Titan
Quanterix (QTRX) director converts 8,073 RSUs, now holds 15,041 shares - Stock Titan
TRIB, QTRX, RCON: Why these stocks are surging after-hours today - MSN
Quanterix (QTRX) director gets 5,472-share stock grant for Q2 2026 board fees - Stock Titan
QTRX Forecast — Price Target — Prediction for 2027 - TradingView
Quanterix Corp sets out growth plans, shares trade on Nasdaq - ad-hoc-news.de
Quanterix Stock Is Popping In Pre-Market: Here's Why - Sahm
Form 4 Quanterix Corp For: 23 June - Investing.com UK
TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today - TradingView
Form 4 Quanterix Corp For: 23 June By Investing.com - Investing.com Nigeria
Quanterix (QTRX) CFO adds stock as RSUs vest and shares withheld - Stock Titan
Quanterix (QTRX) CFO Jason Faessler files initial Form 3 ownership - Stock Titan
QTRXQuanterix Corp Volatility & Greeks - Finviz
Quanterix Corp (QTRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Quanterix Corp (QTRX) Institutional Confidence - TradingKey
Quanterix Corp (QTRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Quanterix Corp (QTRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Quanterix (QTRX) CTO exercises 1,558 RSUs; 467 shares withheld for taxes - Stock Titan
Biotech Quanterix gives new staff 336,804 stock units over 4 years - Stock Titan
Quanterix CCO Benjamin Meadows buys $9,695 in company stock By Investing.com - Investing.com Nigeria
Quanterix (QTRX) Chief Commercial Officer buys 3,500 shares in open-market trade - Stock Titan
Quanterix (QTRX) CCO Benjamin Meadows reports options, RSUs and PSUs in Form 3 - Stock Titan
Quanterix (NASDAQ: QTRX) investors back pay, auditors but reject equity plan - Stock Titan
Quanterix stock falls on CFO appointment announcement - Investing.com
Quanterix Corp Stock (QTRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):